Objective Tests (RCTA)

Two important considerations were the focus of Hybritech v. Monoclonal Antiboties, 802 F.2d 1375.

• A lot of the evidences hinges on laboratory notebooks. The CAFC held that even though the lab notebooks were not witnessed until months or about a year after did not preclude them of being of credible evidentiary value.
• The secondary considerations, commercial success, are not optional considerations. If evidence is available pertaining to them, they must be considered by the court.
• This case also considers the concept of enablement which means that that patent specification must be complete enough so that someone with ordinary skill in the art would be able to make the invention. Enablement is set out in 35 USC 112.